Delivery Order SPE2DR25D2216-SPE2DR26F7UF2
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,248.08 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injectors on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, addressing pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,850.37 for the supply of Xyosted 100 mg/0.5 mL auto-injector units on August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was completed with an ultimate completion date of August 28, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy medication...
- The Defense Logistics Agency awarded a delivery order valued at $9,466.20 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injectors on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy delivered via subcutaneous...
- The Defense Logistics Agency awarded a $2,205.54 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injectors on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injection, representing part of the...
- The Defense Logistics Agency awarded a $1,752.22 delivery order to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injectors on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken, Pennsylvania facility. Xyosted is a testosterone replacement therapy medication delivered via auto-injector, reflecting the Defense...
- The Defense Logistics Agency awarded a $1,937.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies. This competitively awarded, non-set-aside contract was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the military...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,480.15 on November 17, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector units. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy administered via...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,807.85 for Xyosted 75 mg/0.5 mL auto-injector units on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of this injectable testosterone replacement therapy medication for...
- The Defense Logistics Agency awarded a $1,317.52 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for Xyosted 50 mg/0.5 mL auto-injector units with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the agency's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,444.99 on June 3, 2025, for the supply of Xyosted 100 mg/0.5 ml auto-injectors (0.5 ml). This firm fixed-price, competitively awarded delivery order is scheduled for ultimate completion on June 4, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors. Xyosted is...